Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
Market Analysis and Insights: Global Efavirenz Market
The global Efavirenz market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Efavirenz Scope and Segment
The global Efavirenz market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Efavirenz market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Single Efavirenz
Two-drug combination
Three-drug combination
By the end users/application, this report covers the following segments
Adults
Children
Competitive Landscape:
The report provides a list of all the key players in the Efavirenz market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Efavirenz key manufacturers in this market include:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
Market Analysis and Insights: Global Efavirenz Market
The global Efavirenz market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Efavirenz Scope and Segment
The global Efavirenz market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Efavirenz market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Single Efavirenz
Two-drug combination
Three-drug combination
By the end users/application, this report covers the following segments
Adults
Children
Competitive Landscape:
The report provides a list of all the key players in the Efavirenz market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Efavirenz key manufacturers in this market include:
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
1 Efavirenz Market Overview
1.1 Efavirenz Product Overview
1.2 Efavirenz Market Segment by Type
1.2.1 Single Efavirenz
1.2.2 Two-drug combination
1.2.3 Three-drug combination
1.3 Global Efavirenz Market Size by Type
1.3.1 Global Efavirenz Market Size Overview by Type (2016-2027)
1.3.2 Global Efavirenz Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Efavirenz Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Efavirenz Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Efavirenz Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Efavirenz Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Efavirenz Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Efavirenz Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Efavirenz Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Efavirenz Sales Breakdown by Type (2016-2021)
1.4.2 Europe Efavirenz Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Efavirenz Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Efavirenz Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Efavirenz Sales Breakdown by Type (2016-2021)
2 Global Efavirenz Market Competition by Company
2.1 Global Top Players by Efavirenz Sales (2016-2021)
2.2 Global Top Players by Efavirenz Revenue (2016-2021)
2.3 Global Top Players Efavirenz Price (2016-2021)
2.4 Global Top Manufacturers Efavirenz Manufacturing Base Distribution, Sales Area, Product Type
2.5 Efavirenz Market Competitive Situation and Trends
2.5.1 Efavirenz Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Efavirenz Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Efavirenz as of 2020)
2.7 Date of Key Manufacturers Enter into Efavirenz Market
2.8 Key Manufacturers Efavirenz Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Efavirenz Status and Outlook by Region
3.1 Global Efavirenz Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Efavirenz Historic Market Size by Region
3.2.1 Global Efavirenz Sales in Volume by Region (2016-2021)
3.2.2 Global Efavirenz Sales in Value by Region (2016-2021)
3.2.3 Global Efavirenz Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Efavirenz Forecasted Market Size by Region
3.3.1 Global Efavirenz Sales in Volume by Region (2022-2027)
3.3.2 Global Efavirenz Sales in Value by Region (2022-2027)
3.3.3 Global Efavirenz Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Efavirenz by Application
4.1 Efavirenz Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Efavirenz Market Size by Application
4.2.1 Global Efavirenz Market Size Overview by Application (2016-2027)
4.2.2 Global Efavirenz Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Efavirenz Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Efavirenz Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Efavirenz Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Efavirenz Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Efavirenz Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Efavirenz Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Efavirenz Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Efavirenz Sales Breakdown by Application (2016-2021)
4.3.2 Europe Efavirenz Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Efavirenz Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Efavirenz Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Efavirenz Sales Breakdown by Application (2016-2021)
5 North America Efavirenz by Country
5.1 North America Efavirenz Historic Market Size by Country
5.1.1 North America Efavirenz Sales in Volume by Country (2016-2021)
5.1.2 North America Efavirenz Sales in Value by Country (2016-2021)
5.2 North America Efavirenz Forecasted Market Size by Country
5.2.1 North America Efavirenz Sales in Volume by Country (2022-2027)
5.2.2 North America Efavirenz Sales in Value by Country (2022-2027)
6 Europe Efavirenz by Country
6.1 Europe Efavirenz Historic Market Size by Country
6.1.1 Europe Efavirenz Sales in Volume by Country (2016-2021)
6.1.2 Europe Efavirenz Sales in Value by Country (2016-2021)
6.2 Europe Efavirenz Forecasted Market Size by Country
6.2.1 Europe Efavirenz Sales in Volume by Country (2022-2027)
6.2.2 Europe Efavirenz Sales in Value by Country (2022-2027)
7 Asia-Pacific Efavirenz by Region
7.1 Asia-Pacific Efavirenz Historic Market Size by Region
7.1.1 Asia-Pacific Efavirenz Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Efavirenz Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Efavirenz Forecasted Market Size by Region
7.2.1 Asia-Pacific Efavirenz Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Efavirenz Sales in Value by Region (2022-2027)
8 Latin America Efavirenz by Country
8.1 Latin America Efavirenz Historic Market Size by Country
8.1.1 Latin America Efavirenz Sales in Volume by Country (2016-2021)
8.1.2 Latin America Efavirenz Sales in Value by Country (2016-2021)
8.2 Latin America Efavirenz Forecasted Market Size by Country
8.2.1 Latin America Efavirenz Sales in Volume by Country (2022-2027)
8.2.2 Latin America Efavirenz Sales in Value by Country (2022-2027)
9 Middle East and Africa Efavirenz by Country
9.1 Middle East and Africa Efavirenz Historic Market Size by Country
9.1.1 Middle East and Africa Efavirenz Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Efavirenz Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Efavirenz Forecasted Market Size by Country
9.2.1 Middle East and Africa Efavirenz Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Efavirenz Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Efavirenz Business
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Corporation Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Bristol-Myers Squibb Efavirenz Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Teva
10.2.1 Teva Corporation Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Bristol-Myers Squibb Efavirenz Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Corporation Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mylan Efavirenz Products Offered
10.3.5 Mylan Recent Development
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Corporation Information
10.4.2 Aurobindo Pharma Introduction and Business Overview
10.4.3 Aurobindo Pharma Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Aurobindo Pharma Efavirenz Products Offered
10.4.5 Aurobindo Pharma Recent Development
10.5 Cipla
10.5.1 Cipla Corporation Information
10.5.2 Cipla Introduction and Business Overview
10.5.3 Cipla Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Cipla Efavirenz Products Offered
10.5.5 Cipla Recent Development
10.6 Macleods Pharmaceuticals
10.6.1 Macleods Pharmaceuticals Corporation Information
10.6.2 Macleods Pharmaceuticals Introduction and Business Overview
10.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Macleods Pharmaceuticals Efavirenz Products Offered
10.6.5 Macleods Pharmaceuticals Recent Development
10.7 Hetero
10.7.1 Hetero Corporation Information
10.7.2 Hetero Introduction and Business Overview
10.7.3 Hetero Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Hetero Efavirenz Products Offered
10.7.5 Hetero Recent Development
10.8 Strides Pharma
10.8.1 Strides Pharma Corporation Information
10.8.2 Strides Pharma Introduction and Business Overview
10.8.3 Strides Pharma Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Strides Pharma Efavirenz Products Offered
10.8.5 Strides Pharma Recent Development
10.9 Gilead Sciences
10.9.1 Gilead Sciences Corporation Information
10.9.2 Gilead Sciences Introduction and Business Overview
10.9.3 Gilead Sciences Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Gilead Sciences Efavirenz Products Offered
10.9.5 Gilead Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Efavirenz Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Efavirenz Industrial Chain Analysis
11.4 Efavirenz Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Efavirenz Distributors
12.3 Efavirenz Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Efavirenz Product Overview
1.2 Efavirenz Market Segment by Type
1.2.1 Single Efavirenz
1.2.2 Two-drug combination
1.2.3 Three-drug combination
1.3 Global Efavirenz Market Size by Type
1.3.1 Global Efavirenz Market Size Overview by Type (2016-2027)
1.3.2 Global Efavirenz Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Efavirenz Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Efavirenz Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Efavirenz Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Efavirenz Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Efavirenz Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Efavirenz Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Efavirenz Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Efavirenz Sales Breakdown by Type (2016-2021)
1.4.2 Europe Efavirenz Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Efavirenz Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Efavirenz Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Efavirenz Sales Breakdown by Type (2016-2021)
2 Global Efavirenz Market Competition by Company
2.1 Global Top Players by Efavirenz Sales (2016-2021)
2.2 Global Top Players by Efavirenz Revenue (2016-2021)
2.3 Global Top Players Efavirenz Price (2016-2021)
2.4 Global Top Manufacturers Efavirenz Manufacturing Base Distribution, Sales Area, Product Type
2.5 Efavirenz Market Competitive Situation and Trends
2.5.1 Efavirenz Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Efavirenz Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Efavirenz as of 2020)
2.7 Date of Key Manufacturers Enter into Efavirenz Market
2.8 Key Manufacturers Efavirenz Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Efavirenz Status and Outlook by Region
3.1 Global Efavirenz Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Efavirenz Historic Market Size by Region
3.2.1 Global Efavirenz Sales in Volume by Region (2016-2021)
3.2.2 Global Efavirenz Sales in Value by Region (2016-2021)
3.2.3 Global Efavirenz Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Efavirenz Forecasted Market Size by Region
3.3.1 Global Efavirenz Sales in Volume by Region (2022-2027)
3.3.2 Global Efavirenz Sales in Value by Region (2022-2027)
3.3.3 Global Efavirenz Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Efavirenz by Application
4.1 Efavirenz Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Efavirenz Market Size by Application
4.2.1 Global Efavirenz Market Size Overview by Application (2016-2027)
4.2.2 Global Efavirenz Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Efavirenz Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Efavirenz Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Efavirenz Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Efavirenz Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Efavirenz Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Efavirenz Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Efavirenz Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Efavirenz Sales Breakdown by Application (2016-2021)
4.3.2 Europe Efavirenz Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Efavirenz Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Efavirenz Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Efavirenz Sales Breakdown by Application (2016-2021)
5 North America Efavirenz by Country
5.1 North America Efavirenz Historic Market Size by Country
5.1.1 North America Efavirenz Sales in Volume by Country (2016-2021)
5.1.2 North America Efavirenz Sales in Value by Country (2016-2021)
5.2 North America Efavirenz Forecasted Market Size by Country
5.2.1 North America Efavirenz Sales in Volume by Country (2022-2027)
5.2.2 North America Efavirenz Sales in Value by Country (2022-2027)
6 Europe Efavirenz by Country
6.1 Europe Efavirenz Historic Market Size by Country
6.1.1 Europe Efavirenz Sales in Volume by Country (2016-2021)
6.1.2 Europe Efavirenz Sales in Value by Country (2016-2021)
6.2 Europe Efavirenz Forecasted Market Size by Country
6.2.1 Europe Efavirenz Sales in Volume by Country (2022-2027)
6.2.2 Europe Efavirenz Sales in Value by Country (2022-2027)
7 Asia-Pacific Efavirenz by Region
7.1 Asia-Pacific Efavirenz Historic Market Size by Region
7.1.1 Asia-Pacific Efavirenz Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Efavirenz Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Efavirenz Forecasted Market Size by Region
7.2.1 Asia-Pacific Efavirenz Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Efavirenz Sales in Value by Region (2022-2027)
8 Latin America Efavirenz by Country
8.1 Latin America Efavirenz Historic Market Size by Country
8.1.1 Latin America Efavirenz Sales in Volume by Country (2016-2021)
8.1.2 Latin America Efavirenz Sales in Value by Country (2016-2021)
8.2 Latin America Efavirenz Forecasted Market Size by Country
8.2.1 Latin America Efavirenz Sales in Volume by Country (2022-2027)
8.2.2 Latin America Efavirenz Sales in Value by Country (2022-2027)
9 Middle East and Africa Efavirenz by Country
9.1 Middle East and Africa Efavirenz Historic Market Size by Country
9.1.1 Middle East and Africa Efavirenz Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Efavirenz Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Efavirenz Forecasted Market Size by Country
9.2.1 Middle East and Africa Efavirenz Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Efavirenz Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Efavirenz Business
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Corporation Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Bristol-Myers Squibb Efavirenz Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Teva
10.2.1 Teva Corporation Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Bristol-Myers Squibb Efavirenz Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Corporation Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mylan Efavirenz Products Offered
10.3.5 Mylan Recent Development
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Corporation Information
10.4.2 Aurobindo Pharma Introduction and Business Overview
10.4.3 Aurobindo Pharma Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Aurobindo Pharma Efavirenz Products Offered
10.4.5 Aurobindo Pharma Recent Development
10.5 Cipla
10.5.1 Cipla Corporation Information
10.5.2 Cipla Introduction and Business Overview
10.5.3 Cipla Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Cipla Efavirenz Products Offered
10.5.5 Cipla Recent Development
10.6 Macleods Pharmaceuticals
10.6.1 Macleods Pharmaceuticals Corporation Information
10.6.2 Macleods Pharmaceuticals Introduction and Business Overview
10.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Macleods Pharmaceuticals Efavirenz Products Offered
10.6.5 Macleods Pharmaceuticals Recent Development
10.7 Hetero
10.7.1 Hetero Corporation Information
10.7.2 Hetero Introduction and Business Overview
10.7.3 Hetero Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Hetero Efavirenz Products Offered
10.7.5 Hetero Recent Development
10.8 Strides Pharma
10.8.1 Strides Pharma Corporation Information
10.8.2 Strides Pharma Introduction and Business Overview
10.8.3 Strides Pharma Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Strides Pharma Efavirenz Products Offered
10.8.5 Strides Pharma Recent Development
10.9 Gilead Sciences
10.9.1 Gilead Sciences Corporation Information
10.9.2 Gilead Sciences Introduction and Business Overview
10.9.3 Gilead Sciences Efavirenz Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Gilead Sciences Efavirenz Products Offered
10.9.5 Gilead Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Efavirenz Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Efavirenz Industrial Chain Analysis
11.4 Efavirenz Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Efavirenz Distributors
12.3 Efavirenz Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
